Lantos Technologies, Inc., a Cambridge, MA-based developer of a 3D imaging technology that provides accurate and minimally invasive digital mapping of the human ear canal, has closed on $1.6m in a Series A financing.
The round was led by Catalyst Health Ventures, with participation from Excel Venture Management and Mass Medical Angels.
The company’s technology enables development of custom fit audio devices such as hearing aids, earphones and noise-canceling devices.
As stated by Shahid Azim, CEO of Lantos Technologies, the financing will be used to complete product development and enable the market for all types of extended wear hearing devices with a more natural fit.
The company was previously recipient of the innovation grant from MIT’s Deshpande Center, which provided the initial seed capital for primary research.